Bio-Rad's Q3 Revenues Drop 4 Percent on Currency Effects | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its third-quarter revenues slipped nearly 4 percent year over year largely due to the effects of currency translation.

The Hercules, Calif.-based life science research tools firm brought in total revenues of $498.7 million for the three months ended Sept. 30, compared to $516.5 million for the third quarter of 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.